Home Your basket
• New trends in rhinoplasty...
   Price 10.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Papillary carcinoma arisi...
   Price 5.50 €
• Virtual audiovisual talki...
   Price 10.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• Necrotizing external otit...
   Price 10.50 €
• Treatments of hereditary ...
   Price 10.50 €
• Early PTH assay after tot...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• From barotrauma otitis to...
   Price 8.50 €
• High click stimulus repet...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €
• An unusual fester of the ...
   Price 8.50 €
• «Mini-rhinoplasty»...
   Price 10.50 €
• Evaluation of quality of ...
   Price 10.50 €
• Papillary thyroid microca...
   Price 8.50 €
• Benign paroxysmal vertigo...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• The benefit of phoniatric...
   Price 8.50 €
• Study of the supra-glotti...
   Price 10.50 €
• The silent sinus syndrome...
   Price 12.50 €
• MIF in Head and Neck canc...
   Price 10.50 €
• A non-linear model of lar...
   Price 10.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• Otolaryngological aspects...
   Price 8.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• Pleomorphic adenoma of th...
   Price 8.50 €
• Post-operative complicati...
   Price 10.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• Prosodic features of comp...
   Price 10.50 €
• Surgical anatomy of the f...
   Price 10.50 €
• A specific plain X-ray in...
   Price 8.50 €
• Osteoblastoma of the eth...
   Price 10.50 €
• Inferior turbinate hypert...
   Price 10.50 €
• Bilateral facial nerve sc...
   Price 10.50 €
• Vascular tumors of the n...
   Price 10.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Metastatic melanoma to th...
   Price 5.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Vestibular-evoked myogeni...
   Price 10.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• Medical rhinoplasty conce...
   Price 14.00 €
• Combined transoral and su...
   Price 10.50 €
• Migrant foreign body of t...
   Price 10.50 €
• Hygiene and sterilisation...
   Price 10.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Otomycosis: Clinical and ...
   Price 5.50 €
• These lesions of the voca...
   Price 10.50 €
• Myringoplasties for anter...
   Price 10.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• A rare tumor of the parap...
   Price 5.50 €
• Paediatric endoscopic sin...
   Price 10.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Subacute tuberculous otit...
   Price 8.50 €
• Rare benin tumors of the ...
   Price 5.50 €
• Exploration of the otolit...
   Price 10.50 €
• Unilateral frontal sinus ...
   Price 8.50 €
• Fungal infections of para...
   Price 8.50 €
• The European Evaluation o...
   Price 8.50 €
• Voice Handicap Index adap...
   Price 10.50 €
• Autistic like behaviour d...
   Price 8.50 €
• Guidelines for the clinic...
   Price 12.50 €
• Antro choanal polyp in ch...
   Price 10.00 €
• Hearing aid : practical a...
   Price 8.50 €
• Kikuchi's disease as the ...
   Price 10.50 €
• The cost of running a mul...
   Price 5.50 €
• The use of speech therapy...
   Price 10.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Migraine, neurone and ves...
   Price 5.50 €
• Myofibroma of the mandibu...
   Price 8.50 €
• Cochlear implantation in ...
   Price 12.50 €
• Otoplasty: Special attent...
   Price 8.50 €
• Neurofibromatosis Type1 r...
   Price 8.50 €
• Chondrosarcoma of the hyo...
   Price 12.50 €
• A histopathologic evaluat...
   Price 8.50 €
• The supracricoid laryngec...
   Price 10.50 €

Total Order 728.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

PAEDIATRICS

Universal hearing screening in the Champagne-Ardenne regions: Results and consideration after 55 000 births from January 2004 to June 2007


Authors : Langagne T, Schmidt P, Leveque M, Chays A. (Reims)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:153-158.

Article published in french
Downloadable PDF document french



Summary : Aim: This study presents the results of the Universal Newborn Hearing Screening (UNHS) experience in Champagne-Ardenne from January 2004 to June 2007. Materials and methods: A UNHS program was introduced in the entire French region of Champagne-Ardenne in January 2004. Developed upon a strong demand from public and private medical institutions, the program’s aim is the early detection and treatment of bilateral profound or severe hearing loss. The program is composed of 2 steps: the first test is realised in maternity and consists of automated OtoAcoustic Emissions (aOAE). When absent in both ears at first test (positive screening test), the child is referred to a second test 15 days after maternity discharge (aOAE or automated Auditory Brainstem Response (aABR)). If the second test is still failed (positive screening test), the child is referred to a diagnostic procedure (Auditory Brainstem Response) realised by a paediatrician ENT in a reference centre. The UNHS program differs for newborns in Neonatal Intensive Care Units where aABR is realised at first test because of the high frequency of auditory neuropathy in this population. All results are collected in the Regional Neonatal Screening Centre, in charge of the UNHS follow-up. Results: 53 930 newborns benefited from the UNHS program, which represent 98.7% of the 54 790 births in the region during this period. 591 newborns had a positive first test (no aOAE responses) and were referred to the second test. 532 had a negative second test and 46 had a positive second test. 22 children could not have the second test: 4 children deceased, 9 were lost to follow-up (the families moved outside the region) and 9 families refused the second test. The 46 neonates were referred to the diagnostic ABR test and 42 of those 46 babies were diagnosed with neonatal bilateral hearing losses before the age of 6 months. Conclusion: This UNHS experience demonstrates that such UNHS programs are feasible and reliable, at least in a region as wide as Champagne-Ardenne. It achieved to diagnose 42 hearing impaired children, who could benefit from an early intervention for their handicap.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE